메뉴 건너뛰기




Volumn 365, Issue 24, 2011, Pages 2268-2276

Dronedarone in high-risk permanent atrial fibrillation

(588)  Connolly, Stuart J a   Camm, A John b   Halperin, Jonathan L c   Joyner, Campbell d   Alings, Marco e   Amerena, John f   Atar, Dan g   Avezum, Álvaro h   Blomström, Per i   Borggrefe, Martin j   Budaj, Andrzej k   Chen, Shih Ann l   Ching, Chi Keong m   Commerford, Patrick n   Dans, Antonio o   Davy, Jean Marc p   Delacrétaz, Etienne q   Di Pasquale, Giuseppe r   Diaz, Rafael s   Dorian, Paul t   more..


Author keywords

[No Author keywords available]

Indexed keywords

DIGOXIN; DRONEDARONE; PLACEBO; AMIODARONE; ANTIARRHYTHMIC AGENT; DRUG DERIVATIVE;

EID: 84855163167     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1109867     Document Type: Article
Times cited : (549)

References (24)
  • 2
    • 60549097431 scopus 로고    scopus 로고
    • Effect of dronedarone on cardiovascular events in atrial fibrillation
    • Errata, N Engl J Med 2009;360:2487, 2011;364:1481
    • Hohnloser SH, Crijns H, van Eickels M, et al. Effect of dronedarone on cardiovascular events in atrial fibrillation. N Engl J Med 2009;360:668-78. [Errata, N Engl J Med 2009;360:2487, 2011;364:1481.]
    • (2009) N Engl J Med , vol.360 , pp. 668-678
    • Hohnloser, S.H.1    Crijns, H.2    Van Eickels, M.3
  • 3
    • 70349669891 scopus 로고    scopus 로고
    • Analysis of stroke in ATHENA: A placebo-controlled, double-blind, parallelarm trial to assess the efficacy of dronedarone 400 mg BID for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial flutter
    • Connolly SJ, Crijns HJ, Torp-Pedersen C, et al. Analysis of stroke in ATHENA: a placebo-controlled, double-blind, parallelarm trial to assess the efficacy of dronedarone 400 mg BID for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial flutter. Circulation 2009;120:1174-80.
    • (2009) Circulation , vol.120 , pp. 1174-1180
    • Connolly, S.J.1    Crijns, H.J.2    Torp-Pedersen, C.3
  • 5
    • 3042716088 scopus 로고    scopus 로고
    • Progressive nature of paroxysmal atrial fibrillation - Observations from a 14-year follow-up study
    • DOI 10.1253/circj.68.568
    • Kato T, Yamashita T, Sagara K, Linuma H, Fu L. Progressive nature of paroxysmal atrial fibrillation: observations from a 14-year follow-up study. Circ J 2004;68:568-72. (Pubitemid 38856032)
    • (2004) Circulation Journal , vol.68 , Issue.6 , pp. 568-572
    • Kato, T.1    Yamashita, T.2    Sagara, K.3    Iinuma, H.4    Fu, L.-T.5
  • 6
    • 84856195443 scopus 로고    scopus 로고
    • Effect of dronedarone in patients with permanent atrial fibrillation during the ATHENA study
    • abstract
    • Nieuwlaat R, Hohnloser SH, Connolly SJ. Effect of dronedarone in patients with permanent atrial fibrillation during the ATHENA study. Eur Heart J 2011;32:Suppl:618. abstract.
    • (2011) Eur Heart J , vol.32 , Issue.SUPPL. , pp. 618
    • Nieuwlaat, R.1    Hohnloser, S.H.2    Connolly, S.J.3
  • 7
    • 50149084956 scopus 로고    scopus 로고
    • Dronedarone for the control of ventricular rate in permanent atrial fibrillation: The Efficacy and safety of dRonedArone for the cOntrol of ventricular rate during atrial fibrillation (ERATO) study
    • Davy JM, Herold M, Hoglund C, et al. Dronedarone for the control of ventricular rate in permanent atrial fibrillation: the Efficacy and safety of dRonedArone for the cOntrol of ventricular rate during atrial fibrillation (ERATO) study. Am Heart J 2008;156(3):527.e1-527.e9.
    • (2008) Am Heart J , vol.156 , Issue.3
    • Davy, J.M.1    Herold, M.2    Hoglund, C.3
  • 8
    • 0029151139 scopus 로고
    • Interaction of the antiarrhythmic agents SR 33589 and amiodarone with the β2-adrenoceptor and adenylate cyclase in the rat heart
    • Chatelain P, Meysmans L, Matéazzi JR, Beaufort P, Cliniet M. Interaction of the antiarrhythmic agents SR 33589 and amiodarone with the β2-adrenoceptor and adenylate cyclase in the rat heart. Br J Pharmacol 1995;116:1949-56.
    • (1995) Br J Pharmacol , vol.116 , pp. 1949-1956
    • Chatelain, P.1    Meysmans, L.2    Matéazzi, J.R.3    Beaufort, P.4    Cliniet, M.5
  • 9
    • 0029011390 scopus 로고
    • 33589, a new amiodarone-like antiarrhythmic agent: Anti-adrenoceptor activity in anaesthetized and conscious dogs
    • Hodeige D, Heyndrickz JP, Chatelain P, Manning A. SR 33589, a new amiodarone-like antiarrhythmic agent: anti-adrenoceptor activity in anaesthetized and conscious dogs. Eur J Pharmacol 1995;279:25-32.
    • (1995) Eur J Pharmacol , vol.279 , pp. 25-32
    • Hodeige, D.1    Heyndrickz, J.P.2    Chatelain, P.3    Manning Sr., A.4
  • 10
    • 0029120662 scopus 로고
    • Effects of a new amiodarone-like agent, SR 33589, in comparison to amiodarone, D,L-sotalol, and lignocaine, on ischemia-induced ventricular arrhythmias in anesthetized pigs
    • Finance O, Manning A, Chatelain P. Effects of a new amiodarone-like agent, SR 33589, in comparison to amiodarone, D,L-sotalol, and lignocaine, on ischemia-induced ventricular arrhythmias in anesthetized pigs. J Cardiovasc Pharmacol 1995;26:570-6.
    • (1995) J Cardiovasc Pharmacol , vol.26 , pp. 570-576
    • Finance, O.1    Manning, A.2    Chatelain, P.3
  • 11
    • 0029090677 scopus 로고
    • 33589, a new amiodarone-like agent: Effect on ischemia- And reperfusion-induced arrhythmias in anesthetized rats
    • Manning AS, Bruynickx C, Ramboux J, Chatelain P. SR 33589, a new amiodarone-like agent: effect on ischemia- and reperfusion-induced arrhythmias in anesthetized rats. J Cardiovasc Pharmacol 1995;26:453-61.
    • (1995) J Cardiovasc Pharmacol , vol.26 , pp. 453-461
    • Manning, A.S.1    Bruynickx, C.2    Ramboux, J.3    Chatelain Sr., P.4
  • 13
    • 79958267656 scopus 로고    scopus 로고
    • Effect of dronedarone on exercise capacity and cardiac function in patients with severe left ventricular dysfunction and compensated stable heart failure
    • Levine TB, Giles T, Radzik E, Ghali JK. Effect of dronedarone on exercise capacity and cardiac function in patients with severe left ventricular dysfunction and compensated stable heart failure. Cardiovasc Drugs Ther 2010;24:449-58.
    • (2010) Cardiovasc Drugs Ther , vol.24 , pp. 449-458
    • Levine, T.B.1    Giles, T.2    Radzik, E.3    Ghali, J.K.4
  • 16
    • 0021874076 scopus 로고
    • Haemodynamic effects of class I antiarrhythmic agents
    • Legrand V, Collignon P. Haemodynamic effects of class I antiarrhythmic agents. Drugs 1985;29:Suppl 4:54-7. (Pubitemid 15057873)
    • (1985) Drugs , vol.29 , Issue.SUPPL. 4 , pp. 54-57
    • Legrand, V.1    Collignon, P.2
  • 18
    • 77954828276 scopus 로고    scopus 로고
    • Dronedarone in patients with congestive heart failure: Insights from ATHENA
    • Hohnloser SH, Crijns H, van Eickels M, et al. Dronedarone in patients with congestive heart failure: insights from ATHENA. Eur Heart J 2010;31:1717-21.
    • (2010) Eur Heart J , vol.31 , pp. 1717-1721
    • Hohnloser, S.H.1    Crijns, H.2    Van Eickels, M.3
  • 19
    • 33645105413 scopus 로고    scopus 로고
    • Dronedarone: A new antiarrhythmic agent
    • Zarebra KM. Dronedarone: a new antiarrhythmic agent. Drugs Today (Barc) 2006;42:75-86.
    • (2006) Drugs Today (Barc) , vol.42 , pp. 75-86
    • Zarebra, K.M.1
  • 20
    • 0024321898 scopus 로고
    • Preliminary report: Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction
    • The Cardiac Arrhythmia Suppression Trial (CAST) Investigators
    • The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989;321:406-12.
    • (1989) N Engl J Med , vol.321 , pp. 406-412
  • 22
    • 0025303585 scopus 로고
    • Treatment of 150 cases of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments. Final report of a multicenter study
    • Antman EM, Wenger TL, Butler VP Jr, Haber E, Smith TW. Treatment of 150 cases of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments: final report of a multicenter study. Circulation 1990;81:1744-52. (Pubitemid 20183822)
    • (1990) Circulation , vol.81 , Issue.6 , pp. 1744-1752
    • Antman, E.M.1    Wenger, T.L.2    Butler Jr., V.P.3    Haber, E.4    Smith, T.W.5
  • 24
    • 79952761365 scopus 로고    scopus 로고
    • Rhythm- And rate-controlling effects of dronedarone in patients with atrial fibrillation (from the ATHENA trial)
    • Page RL, Connolly SJ, Crijns HJ, et al. Rhythm- and rate-controlling effects of dronedarone in patients with atrial fibrillation (from the ATHENA trial). Am J Cardiol 2011;107:1019-22.
    • (2011) Am J Cardiol , vol.107 , pp. 1019-1022
    • Page, R.L.1    Connolly, S.J.2    Crijns, H.J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.